Main navigation

• Home
• Our medicines
• Diseases and conditions
• Community support
• Help affording your medicines
• Research & development
• Healthcare professionals
• Careers
• About AstraZeneca US
  • Our company
  • AZ on the issues
  • Investors
  • Responsible business
  • Newsroom
    • All news
    • Corporate news
    • Financial news
    • Product news
    • Research news
    • Media resources
  • US web sites
  • Social media sites
  • Contact us

You are here

• Home
• About AstraZeneca US
• Newsroom

• News

The following shows headlines of all news articles published within 12-months, starting from most recent.

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

• • Oct 29, 2009
  • AstraZeneca PLC third quarter and nine months results 2009  
• • Oct 28, 2009
  • Patients taking VIMOVO showed improved UGI tolerability assessments as compared to EC naproxen  
• • Oct 27, 2009
  • Phase 2 data from oral NKTR-118 presented at American College of Gastroenterology in San Diego  
• • Oct 26, 2009
  • AstraZeneca partners with Mercy Primary Care Center to help Michigan uninsured  
• • Oct 19, 2009
  • Patients taking VIMOVO™ showed a decrease in incidence of NSAID-associated ulcers  
• • Oct 16, 2009
  • U.S. Food and Drug Administration approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia  
• • Sep 25, 2009
  • US Court of Appeals affirms Summary Judgment decision in SEROQUEL® patent litigation  
• • Sep 24, 2009
  • Ticagrelor reduced cardiovascular deaths and heart attacks in ACS patients undergoing heart procedures: New data from PLATO trial  
• • Sep 22, 2009
  • AstraZeneca among Working Mother Magazine’s 2009 “Best Companies”  
• • Sep 17, 2009
  • AstraZeneca accepts Secretary Of Defense Award for supporting employees serving in National Guard and Reserve  

• Pages
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• Next

Page tools

• Print
• Bookmark this page
• Subscribe to RSS news feed